dihexa peptide dihexa research | Synthetic | High Purity Dihexa — Peptide Therapy Online

Systolic blood pressure declined by 9.9 mm Hg with the combination and 3.2 mm Hg with placebo (-6.7 mm Hg difference

Mechanism Overview BPC-157 increases growth factors (VEGF, FGF), FAK-paxillin signaling, and also changes the pathways of nitric oxide

Originator Merck carried it through Phase 2 trials and a Phase 2b hip-fracture study but never filed for approval, so there is no FDA-approved prescription version

All doses markedly suppressed food intake compared to vehicle controls, with the 30 and 300 nmol/kg doses producing the strongest anorectic effects, reducing 24-hour food intake by 51% and 57%, respectively

Increasing the dose beyond the effective range adds little benefit regardless of body weight